Raphael Schneider
Cited by
Cited by
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
IL‐27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells
R Schneider, T Yaneva, D Beauseigle, L El‐Khoury, N Arbour
European journal of immunology 41 (1), 47-59, 2011
MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer’s disease
PM McKeever, R Schneider, F Taghdiri, A Weichert, N Multani, RA Brown, ...
Molecular neurobiology 55, 8826-8841, 2018
B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients
R Schneider, AN Mohebiany, I Ifergan, D Beauseigle, P Duquette, A Prat, ...
The Journal of Immunology 187 (8), 4119-4128, 2011
Jump from pre-mutation to pathologic expansion in C9orf72
Z Xi, M van Blitterswijk, M Zhang, P McGoldrick, JR McLean, Y Yunusova, ...
The American Journal of Human Genetics 96 (6), 962-970, 2015
Subacute CNS demyelination after treatment with nivolumab for melanoma
C Maurice, R Schneider, TR Kiehl, P Bavi, MHA Roehrl, WP Mason, ...
Cancer Immunology Research 3 (12), 1299-1302, 2015
Production of IL‐27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses
V Sénécal, G Deblois, D Beauseigle, R Schneider, J Brandenburg, ...
Glia 64 (4), 553-569, 2016
Intrathecal IgM‐synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event
R Schneider, B Euler, S Rauer
European journal of neurology 14 (8), 907-911, 2007
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study
R Schneider, P McKeever, TH Kim, C Graff, JC van Swieten, A Karydas, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (8), 851-858, 2018
Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis
JA Watt, Z Goodarzi, AA Veroniki, V Nincic, PA Khan, M Ghassemi, Y Lai, ...
bmj 372, 2021
Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression
P McGoldrick, M Zhang, M van Blitterswijk, C Sato, D Moreno, S Xiao, ...
Neurology 90 (4), e323-e331, 2018
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
M Zhang, R Ferrari, MC Tartaglia, J Keith, EI Surace, U Wolf, C Sato, ...
Brain 141 (10), 2895-2907, 2018
Use of natalizumab in persons with multiple sclerosis: 2022 update
SA Morrow, F Clift, V Devonshire, E Lapointe, R Schneider, M Stefanelli, ...
Multiple Sclerosis and Related Disorders 65, 103995, 2022
Bruton’s tyrosine kinase inhibition in multiple sclerosis
R Schneider, J Oh
Current neurology and neuroscience reports 22 (11), 721-734, 2022
Glutamate Excitotoxicity in the cerebellum mediated by IL-1β
AN Mohebiany, R Schneider
Journal of Neuroscience 33 (47), 18353-18355, 2013
Neuronal degeneration in a viral model of multiple sclerosis
R Schneider
Journal of Neuroscience 29 (49), 15353-15354, 2009
Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord
R Schneider, JP Tsai, DG Munoz, DH Selchen
Neurology 84 (5), 543-544, 2015
Microvilli expressed on glioma cells keep cytotoxic cells at a distance
F Zaguia, R Schneider
Cancer Biology & Therapy 11 (1), 1-3, 2011
Antibody-positive neuromyelitis optica spectrum disorder after second COVID-19 vaccination: A case report
S Kuntz, G Saab, R Schneider
SN Comprehensive Clinical Medicine 4 (1), 130, 2022
T cells with commitment issues
R Schneider
Science signaling 3 (118), jc3-jc3, 2010
The system can't perform the operation now. Try again later.
Articles 1–20